Optimizing Neonatal Herpes Simplex Virus Evaluations: Influence of In-House Serum Polymerase Chain Reaction Performance on Diagnostic Turnaround, Acyclovir Duration, and Hospital Length of Stay

This study evaluated the impact of the transition to in-house performance of serum herpes simplex virus (HSV) PCRs. Transition to in-house performance reduced diagnostic turnaround times and acyclovir durations, improved evaluation integrity, and expedited discharge in infants with negative diagnost...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the Pediatric Infectious Diseases Society 2024-09, Vol.13 (9), p.501-503
Hauptverfasser:	Patt, Elizabeth M, Ribes, Julie A, Long, Lindsey M, Gardner, Brian M, Howard, Joel I, Schadler, Aric, Olney, Katie B
Format:	Artikel
Sprache:	eng
Schlagworte:	Acyclovir - therapeutic use Antiviral Agents - therapeutic use Female Herpes Simplex - diagnosis Herpes Simplex - drug therapy Humans Infant, Newborn Length of Stay Polymerase Chain Reaction - methods Pregnancy Complications, Infectious - diagnosis Pregnancy Complications, Infectious - drug therapy Pregnancy Complications, Infectious - virology Simplexvirus - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study evaluated the impact of the transition to in-house performance of serum herpes simplex virus (HSV) PCRs. Transition to in-house performance reduced diagnostic turnaround times and acyclovir durations, improved evaluation integrity, and expedited discharge in infants with negative diagnostics.
ISSN:	2048-7207 2048-7207
DOI:	10.1093/jpids/piae072